title: Diagnosis and management of chronic obstructive pulmonary disease: the Swiss guidelines. Official guidelines of the Swiss Respiratory Society.
abstract: The new Swiss Chronic Obstructive Pulmonary Disease (COPD) Guidelines are based on a previous version, which was published 10 years ago. The Swiss Respiratory Society felt the need to update the previous document due to new knowledge and novel therapeutic developments about this prevalent and important disease. The recommendations and statements are based on the available literature, on other national guidelines and, in particular, on the GOLD (Global Initiative for Chronic Obstructive Lung Disease) report. Our aim is to advise pulmonary physicians, general practitioners and other health care workers on the early detection and diagnosis, prevention, best symptomatic control, and avoidance of COPD as well as its complications and deterioration.
authors: Pulmonary Division, Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland. erich.russi@usz.ch
authors: E W
authors: EW
authors: Russi
authors: W
authors: W
authors: Karrer
authors: M
authors: M
authors: Brutsche
authors: C
authors: C
authors: Eich
authors: J W
authors: JW
authors: Fitting
authors: M
authors: M
authors: Frey
authors: T
authors: T
authors: Geiser
authors: M
authors: M
authors: Kuhn
authors: L
authors: L
authors: Nicod
authors: F
authors: F
authors: Quadri
authors: T
authors: T
authors: Rochat
authors: C
authors: C
authors: Steurer-Stey
authors: D
authors: D
authors: Stolz
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D045422:Continuous Positive Airway Pressure; D015444:Exercise; D005100:Expectorants / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007252:Influenza Vaccines; D010092:Oximetry; D010102:Oxygen Inhalation Therapy; D010353:Patient Education as Topic; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D022242:Pneumococcal Vaccines; D011013:Pneumonectomy; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D013902:Radiography, Thoracic; D012129:Respiratory Function Tests; D012138:Respiratory Therapy; D012307:Risk Factors; D012648:Self Care; D012944:Social Support; D011795:Surveys and Questionnaires; D014057:Tomography, X-Ray Computed; D015430:Weight Gain; D000515:alpha 1-Antitrypsin / Q000627:therapeutic use
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists; D005100:Expectorants; D005938:Glucocorticoids; D007252:Influenza Vaccines; D010726:Phosphodiesterase Inhibitors; D022242:Pneumococcal Vaccines; D000515:alpha 1-Antitrypsin